Surveillance, Epidemiology and End Results Program, 1975–2015, Division of Cancer Control and Population Sciences, National Cancer Institute, 2018.Google Scholar

Larsen, EC, Müller, J, Schmiegelow, K et al. Reduced ovarian function in long-term survivors of radiation and chemotherapy-treated childhood cancer. J Clin Endocrinol Met, 2003;88:5307–5314.Google Scholar

Gidoni, Y, Holzer, H, Tulandi, T et al. Fertility preservation in patients with non-oncological conditions. Reprod Biomed Online, 2008;16:792–800.CrossRefGoogle ScholarPubMed

Cobo, A, Bellver, J, Domingo, J et al. New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online, 2008;17:68–72.Google Scholar

Meseguer, M, Molina, N, García-Velasco, JA et al. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril, 2006;85:640–645.CrossRefGoogle ScholarPubMed

Kuwayama, M, Vajta, G, Kato, O et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online, 2005;11:300–308.Google Scholar

Silber, SJ, Derosa, M, Pineda, J et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod, 2008;23:1531–1537.CrossRefGoogle ScholarPubMed

Elgindy, E, Sibai, H, Abdelghani, A et al. Protecting ovaries during chemotherapy through gonad suppression: A systematic review and metaanalysis. Obstet Gynecol, 2015;126:187–195.CrossRefGoogle ScholarPubMed

De Vos, M, Smitz, J, Woodruff, T. Fertility preservation in women with cancer. Lancet, 2014;384:1302–1310.Google Scholar

Tulandi, T, Huang, JY, Tan, SL. Preservation of female fertility: an essential progress. Obstet Gynecol, 2008;112:1160–1172.CrossRefGoogle ScholarPubMed

Bines, J, Oleske, DM, Cobleigh, MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol, 1996;14:1718–1729.CrossRefGoogle ScholarPubMed

Poniatowski, BC, Grimm, P, Cohen, G. Chemotherapy-induced menopause: A literature review. Cancer Invest, 2001;19:641–648.Google Scholar

Meirow, D, Nugent, D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001;7:535–543.Google Scholar

Meirow, D, Epstein, M, Lewis, H et al. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod, 2001;16:632–637.Google Scholar

Martinez, F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril, 2017;108:407–415.Google Scholar

Sonmezer, M, Oktay, K. Fertility preservation in young women undergoing breast cancer therapy. The Oncologist, 2006;11:422–434.Google Scholar

Warne, GL, Fairley, KF, Hobbs, JB et al. Cyclophosphamide-induced ovarian failure. N Engl J Med, 1973;289:1159–1162.CrossRefGoogle ScholarPubMed

Marcello, MF, Nuciforo, G, Romeo, R et al. Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer, 1990;66:2099–2104.3.0.CO;2-3>CrossRefGoogle ScholarPubMed

Familiari, G, Caggiati, A, Nottola, SA et al. Ultrastructure of human primordial follicles after combination chemotherapy for Hodgkin´s disease. Hum Reprod, 1993;8:2080–2087.CrossRefGoogle Scholar

Meirow, D, Dor, J, Kaufman, B et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007;22:1626–1633.Google Scholar

Anderson, RA, Themmen, AP, Al-Qahtani, A et al. The effects of chemotherapy and long term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod, 2006;21:2583–2592.Google Scholar

Wallace, WH, Thomson, AB, Kelsey, TW. The radiosensitivity of human oocyte. Hum Reprod, 2003;18:117–121.Google Scholar

Howell, SJ, Shalet, S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin, 1998;27:927–943.CrossRefGoogle ScholarPubMed

Patrick, K, Wallace, WH, Critchley, H. Late reproductive effects of cancer treatment in female survivors of childhood malignancy. Curr Obstet Gynecol, 2003;13:369–372.CrossRefGoogle Scholar

Goynumer, G, Kayabasoglu, F, Aydogdu, S et al. The effect of tubal sterilization through electrocoagulation on the ovarian reserve. Contraception, 2009;80:90–94.Google Scholar

Hernández-Díaz, S, Werler, MM, Walker, AM et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med, 2000;343:1608–1614.Google Scholar

Alonso, V, Linares, V, Bellés, M et al. Sulfasalazine induced oxidative stress: a possible mechanism of male infertility. Reprod Toxicol, 2009;27:35–40.Google Scholar

Ostensen, , Khamashta, M, Lockshin, M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther, 2006;8:209.CrossRefGoogle ScholarPubMed

Gutierrez, JC, Hwang, K. The toxicity of methotrexate in male fertility and paternal eratogenicity. Expert Opin Drug Metab Toxicol, 2017;1:51–58.CrossRefGoogle Scholar

Martini, AC, Molina, RI, Tissera, AD et al. Analysis of semen from patients chronically treated with low or moderate doses of aspirin like drugs. Fertil Steril, 2003;80:221–222.Google Scholar

Huang, JY, Tulandi, T, Holzer, H et al. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril, 2008;89:567–572.Google Scholar

Tao, T, del Valle, A. Human oocyte and ovarian tissue cryopreservation and its application. J Assist Reprod Genet, 2008;25:287–296.Google Scholar

Cobo, A, Kuwayama, M, Pérez, S et al. Comparison of concomitant outcome achieved with fresh and cryopreserved oocytes vitrified by the Cryotop method. Fertil Steril, 2008;89:1657–1664.Google Scholar

Chian, RC, Huang, JY, Tan, SL et al. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online, 2008;16:608–610.Google Scholar

The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril, 2005;83:1622–1628.Google Scholar

Nugent, D, Meirow, D, Brook, PF et al. Transplantation in reproductive medicine: previous experience, present knowledge and future prospects. Hum Reprod Update, 1997;3:267–280.Google Scholar

Donnez, J, Dolmans, MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet, 2015;32:1167–1170.Google Scholar

Van der Ven, H, Liebenthron, J, Beckmann, M et al. Ninety-five orthotropic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod, 2016;31:2031–2041.CrossRefGoogle Scholar

Diaz-Garcia, C, Domingo, J, Garcia-Velasco, JA et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril, 2018;109:478–485.Google Scholar

Dolmans, MM, Luyckx, V, Donnez, J, Andersen, CY, Greve, T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril, 2013;99:1514–1522.Google Scholar

Shapira, M, Raanani, H, Barshack, I et al. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril, 2018;109:48–53.CrossRefGoogle Scholar

Committee, IP, Kim, SS, Donnez, J et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet, 2012;29:465–468.Google Scholar

Robertson, JA. Ethical issues in ovarian transplantation and donation. Fertil Steril, 2000;73:443–446.Google Scholar

Blumenfeld, Z, Evron, A. Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol, 2016;28:223–229.Google Scholar

Del Mastro, L, Ceppi, M, Poggio, F et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev, 2014;40:675–683.Google Scholar

Srkalovic, G, Schally, AV, Wittliff, JL et al. Presence and characteristics of receptors for [D-Trp6] luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer. Int J Oncol, 1998;12:489–498.Google ScholarPubMed

Emous, G, Grndker, C, Ganthert, AR et al. GnRH antagonists in the treatment of gynaecological and breast cancer. Endocr Relat Cancer, 2003;10:291–299.Google Scholar

Blumenfeld, Z, Shapiro, D, Shteinberg, M et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus, 2000;9:401–405.Google Scholar

Gougeon, A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev, 1996;17:121–155.Google Scholar

Chian, RC, Huang, JY, Gilbert, L et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril, 2009;91:2391–2398.Google Scholar

Cohen, Y, St-Onge-St-Hilaire, A, Tannus, S et al. Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes. J Assist Reprod Genet. 2018;35(9):1683–1689.CrossRefGoogle Scholar

Buckett, WM, Chian, RC, Dean, NL et al. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril, 2008;90:546–550.Google Scholar

Bisharah, M, Tulandi, T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol, 2003;188:367–370.CrossRefGoogle ScholarPubMed

Chen, Y, Sun, J, Zou, K et al. Treatment for lupus nephritis: an overview of systematic reviews and meta-analyses. Rheumatol Int, 2017;37:1089–1099.Google Scholar

Bernatsky, S, Clarke, A, Suissa, S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med, 2008;168:378–381.Google Scholar

Langford, C. Wegener’s granulomatosis: current and upcoming therapies. Arthritis Res Ther, 2003;5:180–191.CrossRefGoogle ScholarPubMed

Schroeder, JO, Euler, H, Loffler, H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med, 1987;107:344–346.Google Scholar

Manger, K, Wildt, L, Kalden, JR et al. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev, 2006;5:269–272.Google Scholar

Buyon, JP, Petri, MA, Kim, MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med, 2005;142:953–962.Google Scholar

Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metabol, 2006;91:3885–3890.CrossRefGoogle ScholarPubMed

Ahlstrom, A, Westin, C, Wikland, M et al. Prediction of live birth in frozen-thawed single blastocyst transfer cycles by pre-freeze and post-thaw morphology. Hum Reprod, 2013;28:1199–1209.Google Scholar

Goldman, RH, Racowsky, C, Farland, LV et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod, 2017;32:853–859.CrossRefGoogle ScholarPubMed

Dondorp, WJ, De Wert, GM. Fertility preservation for healthy women: ethical aspects. Hum Reprod, 2009;24:1779–1785.CrossRefGoogle ScholarPubMed

Cobo, A, Garcia-Velasco, JA, Coello, A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril, 2016;105:755–764.e8.Google Scholar

Cobo A, García-Velasco JA, Domingo J, Pellicer A, Remohí J. Elective and Onco-fertility preservation: factors related to IVF outcomes. Hum Reprod, 2018;33(12):2222–2231.Google Scholar

Somigliana, E, Ragni, G, Benedetti, F et al. Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod, 2003;18:2450–2453.CrossRefGoogle ScholarPubMed

Carrillo, L, Seidman, D, Cittadini, E et al. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet, 2016;33:317–323.CrossRefGoogle ScholarPubMed

García-Velasco, JA, Somigliana, E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod, 2009;24:496–501.CrossRefGoogle ScholarPubMed

Busacca, M, Vignali, M. Endometrioma excision and ovarian reserve: a dangerous relation. J Minim Invasive Gynecol, 2009;16:142–148.Google Scholar

Rauck, AM, Grouas, AC. Bone marrow transplantation in adolescents. Adolesc Med, 1999;10:445–449.Google Scholar

Lau, NM, Huang, JY, MacDonald, S et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online, 2009;18:290–295.Google Scholar

Pienkowski, C, Menendez, M, Cartault, A et al. Turner’s syndrome and procreation. Ovarian function and Turner’s syndrome. Gynecol Obstet Fertil, 2008;36:1030–1034.Google Scholar

Sénéchal, C, Rousset-Jablonski, C. Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation? Gynecol Obstet Fertil, 2015;43:800–805.Google Scholar

Derks-Smeets, IAP, van Tilborg, TC, van Montfoort, A et al. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD. J Assist Reprod Genet, 2017;34:1475–1482.CrossRefGoogle ScholarPubMed

Cobo, A, Bellver, J, Domingo, J et al. New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online, 2008;17:68–72.Google Scholar

Bosch, E, Labarta, E, Crespo, J et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod, 2010;25:2092–2100.Google Scholar

Wheeler, JM. Epidemiology of endometriosis-associated infertility. J Reprod Med, 1989;34(1):41–46.Google Scholar

Giudice, LC, Kao, LC. Endometriosis. Lancet, 2004;364(9447):1789–1799.Google Scholar

Rogers, PA, D’Hooghe, TM, Fazleabas, A et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci, 2009;16(4):335–346.Google Scholar

Nisolle, M, Donnez, J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril, 1997;68(4):585–596.Google Scholar

Seyhan, A, Ata, B, Uncu, G. The impact of endometriosis and its treatment on ovarian reserve. Semin Reprod Med, 2015;33(6):422–428.Google Scholar

Giudice, LC. Clinical practice. Endometriosis. N Engl J Med, 2010;362(25):2389–2398.Google Scholar

Sanchez, AM, Vigano, P, Somigliana, E et al. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update, 2014;20(2):217–230.Google Scholar

Kitajima, M, Defrere, S, Dolmans, MM et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril, 2011;96(3):685–691.CrossRefGoogle ScholarPubMed

Vercellini, P, Chapron, C, De Giorgi, O et al. Coagulation or excision of ovarian endometriomas? Am J Obstet Gynecol, 2003;188(3):606–610.Google Scholar

Donnez, J, Chantraine, F, Nisolle, M. The efficacy of medical and surgical treatment of endometriosis-associated infertility: arguments in favour of a medico-surgical approach. Hum Reprod Update, 2002;8(1):89–94.CrossRefGoogle Scholar

Exacoustos, C, Zupi, E, Amadio, A et al. Laparoscopic removal of endometriomas: sonographic evaluation of residual functioning ovarian tissue. Am J Obstet Gynecol, 2004;191(1):68–72.Google Scholar

Muzii, L, Bellati, F, Bianchi, et al. Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Part II: pathological results. Hum Reprod, 2005;20(7):1987–1992.CrossRefGoogle ScholarPubMed

Hart, RJ, Hickey, M, Maouris, P, Buckett, W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev, 2008;2:CD004992.Google Scholar

Raffi, F, Metwally, M, Amer, S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab, 2012;97(9):3146–3154.Google Scholar

Meenakshi, M, McCluggage, WG. Vascular involvement in adenomyosis: report of a large series of a common phenomenon with observations on the pathogenesis of adenomyosis. Int J Gynecol Pathol, 2010;29(2):117–121.Google Scholar

Donnez, J, Dolmans, MM. The ovary: from conception to death. Fertil Steril, 2017;108(4):594–595.Google Scholar

Wallace, WH, Kelsey, TW. Human ovarian reserve from conception to the menopause. PLoS One, 2010;5(1):e8772.Google Scholar

Schubert, B, Canis, M, Darcha, C et al. Human ovarian tissue from cortex surrounding benign cysts: a model to study ovarian tissue cryopreservation. Hum Reprod, 2005;20(7):1786–1792.Google Scholar

Maneschi, F, Marasa, L, Incandela, S, Mazzarese, M, Zupi, E. Ovarian cortex surrounding benign neoplasms: a histologic study. Am J Obstet Gynecol, 1993; 169 (2 Pt 1): 388–393.Google Scholar

Van Langendonckt, A, Donnez, J, Defrere, S, Dunselman, GA, Groothuis, PG. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Mol Hum Reprod, 2008;14(5):259–268.CrossRefGoogle ScholarPubMed

Oktem, O, Urman, B. Understanding follicle growth in vivo. Hum Reprod, 2010;25(12):2944–2954.CrossRefGoogle ScholarPubMed

Skinner, MK. Regulation of primordial follicle assembly and development. Hum Reprod Update, 2005;11(5):461–471.Google Scholar

Motta, PM, Nottola, SA, Familiari, G et al. Morphodynamics of the follicular-luteal complex during early ovarian development and reproductive life. Int Rev Cytol, 2003;223:177–288.Google Scholar

Kitajima, M, Dolmans, MM, Donnez, O et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril, 2014;101(4):1031–1037.CrossRefGoogle ScholarPubMed

Sanchez, AM, Papaleo, E, Corti, L et al. Iron availability is increased in individual human ovarian follicles in close proximity to an endometrioma compared with distal ones. Hum Reprod, 2014;29(3):577–583.Google Scholar

Ferrero, S, Barra, F, Maggiore, ULR. Current and emerging therapeutics for the management of endometriosis. Drugs, 2018;78(10):995–1012.Google Scholar

Dolmans, MM, Martinez-Madrid, B, Gadisseux, E et al. Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice. Reproduction, 2007;134(2):253–262.Google Scholar

Donnez, J, Lousse, JC, Jadoul, P, Donnez, O, Squifflet, J. Laparoscopic management of endometriomas using a combined technique of excisional (cystectomy) and ablative surgery. Fertil Steril, 2010;94(1):28–32.Google Scholar

Working group of Esge, E, Wes, , Saridogan, E, Becker, CM et al. Recommendations for the surgical treatment of endometriosis-part 1: ovarian endometrioma. Gynecol Surg, 2017;14(1):27.Google Scholar

Donnez, J, Garcia-Solares, J, Dolmans, MM. Ovarian endometriosis and fertility preservation: a challenge in 2018. Minerva Ginecol, 2018;70(4):408–414.Google Scholar

Donnez, J, Wyns, C, Nisolle, M. Does ovarian surgery for endometriomas impair the ovarian response to gonadotropin? Fertil Steril, 2001;76(4):662–665.Google Scholar

Carmona, F, Martinez-Zamora, MA, Rabanal, A, Martinez-Roman, S, Balasch, J. Ovarian cystectomy versus laser vaporization in the treatment of ovarian endometriomas: a randomized clinical trial with a five-year follow-up. Fertil Steril, 2011;96(1):251–254.Google Scholar

Dunselman, GA, Vermeulen, N, Becker, C et al. ESHRE guideline: management of women with endometriosis. Hum Reprod, 2014;29(3):400–412.CrossRefGoogle ScholarPubMed

Falcone, T, Flyckt, R. Clinical management of endometriosis. Obstet Gynecol, 2018;131(3):557–571.Google Scholar

Carrillo, L, Seidman, DS, Cittadini, E, Meirow, D. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet, 2016;33(3):317–323.Google Scholar

Hirokawa, W, Iwase, A, Goto, M et al. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod, 2011;26(4):904–910.Google Scholar

Aimetti, M, Manavella, V, Corano, L et al. Three-dimensional analysis of bone remodeling following ridge augmentation of compromised extraction sockets in periodontitis patients: A randomized controlled study. Clin Oral Implants Res, 2018;29(2):202–214.Google Scholar

Roman, H. Endometriosis surgery and preservation of fertility, what surgeons should know. J Visc Surg, 2018;155(Suppl 1):S31–S36.Google Scholar

Donnez, J. Reply of the authors to I. Brosens. Fertil Steril, 2010;94:e74.Google Scholar

Garavaglia, E, Sala, C, Taccagni, G et al. Fertility preservation in endometriosis patients: Anti-Mullerian hormone is a reliable marker of the ovarian follicle density. Front Surg, 2017;4:40.Google Scholar

Anderson, RA, Wallace, WH. Antimullerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil Steril, 2013;99(6):1469–1475.Google Scholar

Muzii, L, Luciano, AA, Zupi, E, Panici, PB. Effect of surgery for endometrioma on ovarian function: a different point of view. J Minim Invasive Gynecol, 2014;21(4):531–533.Google Scholar

Shah, DK, Mejia, RB, Lebovic, DI. Effect of surgery for endometrioma on ovarian function. J Minim Invasive Gynecol, 2014;21(2):203–209.Google Scholar

Practice Committee of the American Society for Reproductive M. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril, 2012;98(6):1407–1415.Google Scholar

Somigliana, E, Berlanda, N, Benaglia, L et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril, 2012;98(6):1531–1538.CrossRefGoogle ScholarPubMed

Goodman, LR, Goldberg, JM, Flyckt, RL et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol, 2016;215(5):589 e1e6.Google Scholar

Turkcuoglu, I, Melekoglu, R. The long-term effects of endometrioma surgery on ovarian reserve: a prospective case-control study. Gynecol Endocrinol, 2018;34(7):612–615.Google Scholar

Collinet, P, Fritel, X, Revel-Delhom, C et al. Management of endometriosis: CNGOF/HAS clinical practice guidelines – Short version. J Gynecol Obstet Hum Reprod, 2018;47(7):265–274.Google Scholar

Dolmans, MM, Donnez, J. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline. Minerva Ginecol, 2018;70(4):402–407.Google Scholar

Chen, C. Pregnancy after human oocyte cryopreservation. Lancet, 1986;1(8486):884–886.Google Scholar

Cobo, A, Diaz, C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril, 2011;96(2):277–285.Google Scholar

Argyle, CE, Harper, JC, Davies, MC. Oocyte cryopreservation: where are we now? Hum Reprod Update, 2016;22(4):440–449.Google Scholar

Levi-Setti, PE, Patrizio, P, Scaravelli, G. Evolution of human oocyte cryopreservation: slow freezing versus vitrification. Curr Opin Endocrinol Diabetes Obes, 2016;23(6):445–450.Google Scholar

Rienzi, L, Gracia, C, Maggiulli, R et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update, 2017;23(2):139–155.Google Scholar

Cobo, A, Garcia-Velasco, JA, Coello, A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril, 2016;105(3):755–764 e8.Google Scholar

Donnez, J, Dolmans, MM. Fertility preservation in women. N Engl J Med, 2017;377(17):1657–1665.Google Scholar

Donnez, J, Dolmans, MM. Fertility preservation in women. Nat Rev Endocrinol, 2013;9(12):735–749.Google Scholar

Bedoschi, G, Oktay, K. Current approach to fertility preservation by embryo cryopreservation. Fertil Steril, 2013;99(6):1496–1502.Google Scholar

Donnez, J, Nisolle, M, Gillet, N et al. Large ovarian endometriomas. Hum Reprod, 1996;11(3):641–646.Google Scholar

Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril, 2014;101(5):1237–1243.Google Scholar

Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril, 2012;98(3):591–598.Google Scholar

Cil, AP, Bang, H, Oktay, K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril, 2013;100(2):492–499 e3.Google Scholar

Silber, SJ, Lenahan, KM, Levine, DJ et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N Engl J Med, 2005;353(1):58–63.Google Scholar

Silber, SJ, Grudzinskas, G, Gosden, RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med, 2008;359(24):2617–2618.Google Scholar

Silber, SJ, DeRosa, M, Pineda, J et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod, 2008;23(7):1531–1537.Google Scholar

Silber, SJ, Gosden, RG. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure. N Engl J Med, 2007;356(13):1382–1384.Google Scholar

Donnez, J, Squifflet, J, Dolmans, MM et al. Orthotopic transplantation of fresh ovarian cortex: a report of two cases. Fertil Steril, 2005;84(4):1018.Google Scholar

Donnez, J, Martinez-Madrid, B, Jadoul, P et al. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update, 2006;12(5):519–535.Google Scholar

Donnez, J, Dolmans, MM, Demylle, D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet, 2004;364(9443):1405–1410.Google Scholar

Gellert, SE, Pors, SE, Kristensen, SG et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet, 2018;35(4):561–570.Google Scholar

Ernst, E, Bergholdt, S, Jorgensen, JS, Andersen, CY. The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod, 2010;25(5):1280–1281.Google Scholar

Donnez, J, Dolmans, MM, Pellicer, A et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril, 2013;99(6):1503–1513.Google Scholar

Jadoul, P, Guilmain, A, Squifflet, J et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod, 2017;32(5):1046–1054.Google Scholar

Meirow, D, Ra’anani, H, Shapira, M et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril, 2016;106(2):467–474.Google Scholar

Jensen, AK, Macklon, KT, Fedder, J et al. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. J Assist Reprod Genet, 2017;34(3):325–336.Google Scholar

Van der Ven, H, Liebenthron, J, Beckmann, M et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod, 2016;31(9):2031–2041.CrossRefGoogle Scholar

Demeestere, I, Simon, P, Emiliani, S, Delbaere, A, Englert, Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist, 2007;12(12):1437–1442.Google Scholar

Schmidt, KT, Nyboe Andersen, A, Greve, T. Fertility in cancer patients after cryopreservation of one ovary. Reprod Biomed Online, 2013;26(3):272–279.Google Scholar

Jadoul, P, Dolmans, MM, Donnez, J. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? Hum Reprod Update, 2010;16(6):617–630.Google Scholar

Donnez, J, Dolmans, MM, Diaz, C, Pellicer, A. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril, 2015;104(5):1097–1098.Google Scholar

Donnez, J, Dolmans, MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet, 2015;32(8):1167–1170.Google Scholar

Donnez, J, Squifflet, J, Jadoul, P et al. Fertility preservation in women with ovarian endometriosis. Front Biosci (Elite Ed), 2012;4:1654–1662.Google Scholar

Dittrich, R, Lotz, L, Keck, G et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril, 2012;97(2):387–390.Google Scholar

Noone, AM, Howlader, N, Noone, AM et al. SEER cancer statistics review, 1975–2015. National Cancer Institute 2018.Google Scholar

Phillips, SM, Padgett, LS, Leisenring, WM et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev, 2015;24:653–663.Google Scholar

Oeffinger, KC, Mertens, AC, Sklar, CA et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med, 2006;355:1572–1582.Google Scholar

Hudson, MM, Ness, KK, Gurney, JG et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA, 2013;309:2371–2381.Google Scholar

Chow, EJ, Stratton, KL, Leisenring, WM et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol, 2016;17:567–576.Google Scholar

Knapp, CA, Quinn, GP, Murphy, D. Assessing the reproductive concerns of children and adolescents with cancer: Challenges and potential solutions. J Adolesc Young Adult Oncol, 2011;1:31–35.Google Scholar

Quinn, GP, Woodruff, TK, Knapp, CA. Expanding the oncofertility workforce: training allied health professionals to improve health outcomes for adolescents and young adults. J Adolesc Young Adult Oncol, 2016;5:292–296.Google Scholar

Carlson, CA, Kolon, TF, Mattei, P. Developing a hospital-wide fertility reservation service for pediatric and young adult patients. J Adolesc Health, 2017;61:571–576.Google Scholar

Sklar, C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol, 1999;33:2–8.Google Scholar

Kubota, H, Brinster, RL. Spermatogonial stem cells. Biol Reprod, 2018;99(1):52–74.Google Scholar

Howell, SJ, Shalet, SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr, 2005;34:12–17.Google Scholar

Wallace, WH. Oncofertility and preservation of reproductive capacity in children and young adults. Cancer, 2011;117:2301–2310.Google Scholar

Meistrich, ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril, 2013;100:1180–1186.Google Scholar

van Casteren, NJ, van der Linden, GH, Hakvoort-Cammel, FG et al. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer, 2009;52:108–112.Google Scholar

Holoch, P, Wald, M. Current options for preservation of fertility in the male. Fertil Steril, 2011;96:286–290.Google Scholar

Pryzant, RM, Meistrich, ML, Wilson, G. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin’s lymphomas. J Clin Oncol, 1993;11:239–247.Google Scholar

Meistrich, ML, Wilson, G, Brown, BW, da Cunha, MF, Lipshultz, LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer, 1992;70:2703–2712.Google Scholar

Kenney, LB, Laufer, MR, Grant, FD, Grier, H, Diller, L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer, 2001;91:613–621.Google Scholar

Green, DM, Liu, W, Kutteh, WH et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol, 2014;15:1215–1223.Google Scholar

Viviani, S, Santoro, A, Ragni, G et al. Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol, 1985;21:601–605.Google Scholar

Marmor, D, Duyck, F. Male reproductive potential after MOPP therapy for Hodgkin’s disease: a long-term survey. Andrologia, 1995;27:99–106.Google Scholar

Dohle, GR. Male infertility in cancer patients: Review of the literature. Int J Urol, 2010;17:327–331.Google Scholar

Paoli, D, Rizzo, F, Fiore, G et al. Spermatogenesis in Hodgkin’s lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Hum Reprod, 2016;31:263–272.Google Scholar

Behringer, K, Mueller, H, Goergen, H et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol, 2013;31:231–239.Google Scholar

Waring, AB, Wallace, WH. Subfertility following treatment for childhood cancer. Hosp Med, 2000;61:550–557.Google Scholar

Chovanec, M, Abu Zaid, M, Hanna, N et al. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol, 2017;28:2670–2679.Google Scholar

Pont, J, Albrecht, W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril, 1997;68:1–5.Google Scholar

Hansen, PV, Hansen, SW. Gonadal function in men with testicular germ cell cancer: the influence of cisplatin-based chemotherapy. Eur Urol, 1993;23:153–156.Google Scholar

Meistrich, M, Chawla, SP, da Cunha, MF et al. Recovery of sperm production after chemotherapy for osteosarcoma. Cancer, 1989;63:2115–2123.Google Scholar

Brignardello, E, Felicetti, F, Castiglione, A et al. Gonadal status in long-term male survivors of childhood cancer. J Cancer Res Clin Oncol, 2016;142:1127–1132.CrossRefGoogle ScholarPubMed

Longhi, A, Macchiagodena, M, Vitali, G, Bacci, G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol, 2003;25:292–296.Google Scholar

Janeway, KA, Grier, HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol, 2010;11:670–678.Google Scholar

Williams, D, Crofton, PM, Levitt, G. Does ifosfamide affect gonadal function? Pediatr Blood Cancer, 2008;50:347–351.Google Scholar

Jacob, A, Barker, H, Goodman, A, Holmes, J. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transplant, 1998;22:277–279.Google Scholar

Sanders, JE, Hawley, J, Levy, W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 1996;87:3045–3052.Google Scholar

Ash, P. The influence of radiation on fertility in man. Br J Radiol, 1980;53:271–278.Google Scholar

Kenney, LB, Cohen, LE, Shnorhavorian, M et al. Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children’s Oncology Group. J Clin Oncol, 2012;30:3408–3416.Google Scholar

Blatt, J, Sherins, RJ, Niebrugge, D, Bleyer, WA, Poplack, DG. Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol, 1985;3:1227–1231.Google Scholar

Castillo, LA, Craft, AW, Kernahan, J, Evans, RG, Aynsley-Green, A. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia. Med Pediatr Oncol, 1990;18:185–189.Google Scholar

Sklar, CA, Robison, LL, Nesbit, ME et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol, 1990;8:1981–1987.Google Scholar

Shapiro, E, Kinsella, TJ, Makuch, RW et al. Effects of fractionated irradiation of endocrine aspects of testicular function. J Clin Oncol, 1985;3:1232–1239.Google Scholar

Fraass, BA, Kinsella, TJ, Harrington, FS, Glatstein, E. Peripheral dose to the testes: the design and clinical use of a practical and effective gonadal shield. Int J Radiat Oncol Biol Phys, 1985;11:609–615.Google Scholar

Socie, G, Salooja, N, Cohen, A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood, 2003;101:3373–3385.Google Scholar

Sayan, M, Cassidy, RJ, Butker, EE et al. Gonadal shielding technique to preserve fertility in male pediatric patients treated with total body irradiation for stem cell transplantation. Bone Marrow Transplant, 2016;51:997–998.Google Scholar

Speiser, B, Rubin, P, Casarett, G. Aspermia following lower truncal irradiation in Hodgkin’s disease. Cancer, 1973;32:692–698.Google Scholar

Sandeman, TF. The effects of x irradiation on male human fertility. Br J Radiol, 1966;39:901–907.Google Scholar

Djaladat, H, Burner, E, Parikh, PM, Beroukhim Kay, D, Hays, K. The association between testis cancer and semen abnormalities before orchiectomy: a systematic review. J Adolesc Young Adult Oncol, 2014;3:153–159.Google Scholar

Kenney, LB, Antal, Z, Ginsberg, JP et al. Improving male reproductive health after childhood, adolescent, and young adult cancer: progress and future directions for survivorship research. J Clin Oncol, 2018;36:2160–2168.Google Scholar

Crowne, E, Gleeson, H, Benghiat, H, Sanghera, P, Toogood, A. Effect of cancer treatment on hypothalamic-pituitary function. Lancet Diabetes Endocrinol, 2015;3:568–576.Google Scholar

Darzy, KH, Shalet, SM. Hypopituitarism following radiotherapy revisited. Endocr Dev, 2009;15:1–24.Google Scholar

Schmiegelow, M, Lassen, S, Poulsen, HS et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab, 2001;86:2446–2452.Google Scholar

Constine, LS, Woolf, PD, Cann, D et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med, 1993;328:87–94.Google Scholar

Ogle, SK, Hobbie, WL, Carlson, CA et al. Sperm banking for adolescents with cancer. J Pediatr Oncol Nurs, 2008;25:97–101.Google Scholar

Klosky, JL, Lehmann, V, Flynn, JS et al. Patient factors associated with sperm cryopreservation among at-risk adolescents newly diagnosed with cancer. Cancer, 2018;124:3567–3575.Google Scholar

Ginsberg, JP, Ogle, SK, Tuchman, LK et al. Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives. Pediatr Blood Cancer, 2008;50:594–598.Google Scholar

DiNofia, AM, Wang, X, Yannekis, G et al. Analysis of semen parameters in a young cohort of cancer patients. Pediatr Blood Cancer, 2017;64:381–386.Google Scholar

Yu, G, Liu, Y, Zhang, H, Wu, K. Application of testicular spermatozoa cryopreservation in assisted reproduction. Int J Gynaecol Obstet, 2018;142:354–358.Google Scholar

Adank, MC, van Dorp, W, Smit, M et al. Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature. Fertil Steril, 2014;102:199–205 e191.Google Scholar

Jurewicz, M, Hillelsohn, J, Mehta, S, Gilbert, BR. Fertility preservation in pubertal and pre-pubertal boys with cancer. Pediatr Endocrinol Rev, 2018;15:234–243.Google Scholar

Brinster, RL. Male germline stem cells: from mice to men. Science, 2007;316:404–405.Google Scholar

Hermann, BP, Sukhwani, M, Winkler, F et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell, 2012;11:715–726.Google Scholar

Bhang, DH, Kim, BJ, Kim, BG et al. Testicular endothelial cells are a critical population in the germline stem cell niche. Nat Commun, 2018;9:4379.Google Scholar

Ginsberg, JP, Carlson, CA, Lin, K et al. An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety. Hum Reprod, 2010;25:37–41.Google Scholar

Richards, JS. Perspective: the ovarian follicle–a perspective in 2001. Endocrinology, 2001;142:2184–2193.Google Scholar

Banerjee, S, Banerjee, S, Saraswat, G, Bandyopadhyay, SA, Kabir, SN. Female reproductive aging is master-planned at the level of ovary. PLoS One, 2014;9: e96210.Google Scholar

Mattison, DR, Plowchalk, DR, Meadows, MJ et al. Reproductive toxicity: male and female reproductive systems as targets for chemical injury. Med Clin North Am, 1990;74:391–411.Google Scholar

Gargus, E, Deans, R, Anazodo, A, Woodruff, TK. Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer. J Natl Compr Canc Netw, 2018;16:1137–1149.Google Scholar

Levine, JM, Whitton, JA, Ginsberg, JP et al. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer, 2018;124:1044–1052.Google Scholar

Chemaitilly, W, Li, Z, Krasin, MJ et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort. J Clin Endocrinol Metab, 2017;102:2242–2250.Google Scholar

Oktem, O, Kim, SS, Selek, U, Schatmann, G, Urman, B. Ovarian and uterine functions in female survivors of childhood cancers. Oncologist, 2018;23:214–224.Google Scholar

Oktem, O, Oktay, K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer, 2007;110:2222–2229.Google Scholar

Chemaitilly, W, Mertens, AC, Mitby, P et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab, 2006;91:1723–1728.Google Scholar

Gracia, CR, Ginsberg, JP. Fertility risk in pediatric and adolescent cancers. Cancer Treat Res, 2007;138:57–72.Google Scholar

Thomas-Teinturier, C, Allodji, RS, Svetlova, E et al. Ovarian reserve after treatment with alkylating agents during childhood. Hum Reprod, 2015;30:1437–1446.Google Scholar

Green, DM, Kawashima, T, Stovall, M et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol, 2009;27:2677–2685.Google Scholar

De Bruin, ML, Huisbrink, J, Hauptmann, M et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood, 2008;111:101–108.Google Scholar

Sklar, CA, Mertens, AC, Mitby, P et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst, 2006;98:890–896.Google Scholar

van Dorp, W, Haupt, R, Anderson, RA et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol, 2018;36:2169–2180.Google Scholar

Overbeek, A, van den Berg, MH, van Leeuwen, FE et al. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review. Cancer Treat Rev, 2017;53:10–24.Google Scholar

Borgmann-Staudt, A, Rendtorff, R, Reinmuth, S et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant, 2012;47:271–276.Google Scholar

Thibaud, E, Rodriguez-Macias, K, Trivin, C et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant, 1998;21:287–290.Google Scholar

Sanders, JE, Woolfrey, AE, Carpenter, PA et al. Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood, 2011;118:1421–1428.Google Scholar

Vatanen, A, Wilhelmsson, M, Borgstrom, B et al. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence. Eur J Endocrinol, 2014;170:211–218.Google Scholar

Nabhan, SK, Bitencourt, MA, Duval, M et al. Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients. Haematologica, 2010;95:1783–1787.Google Scholar

Singhal, S, Powles, R, Treleaven, J et al. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant, 1996;18:1049–1055.Google Scholar

Panasiuk, A, Nussey, S, Veys, P et al. Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan. Br J Haematol, 2015;170:719–726.Google Scholar

Wallace, WH, Thomson, AB, Kelsey, TW. The radiosensitivity of the human oocyte. Hum Reprod, 2003;18:117–121.Google Scholar

Wallace, WH, Thomson, AB, Saran, F, Kelsey, TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys, 2005;62:738–744.Google Scholar

Wallace, WH, Shalet, SM, Hendry, JH, Morris-Jones, PH, Gattamaneni, HR. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol, 1989;62:995–998.Google Scholar

Beneventi, F, Locatelli, E, Giorgiani, G et al. Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases. BJOG, 2014;121:856–865; discussion 865.Google Scholar

Teh, WT, Stern, C, Chander, S, Hickey, M. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int, 2014;2014:482968.Google Scholar

Koustenis, E, Pfitzer, C, Balcerek, M et al. Impact of cranial irradiation and brain tumor location on fertility: a survey. Klin Padiatr, 2013;225:320–324.Google Scholar

Green, DM, Nolan, VG, Kawashima T et al. Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril, 2011; 95(6):1922–1927, 1927 e1.Google Scholar

Hamre, MR, Robison, LL, Nesbit, ME et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children’s Cancer Study Group. J Clin Oncol, 1987;5:1759–1765.Google Scholar

Wallace, WH, Shalet, SM, Tetlow, LJ, Morris-Jones, PH. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol, 1993;21:333–339.Google Scholar

DeWire, M, Green, DM, Sklar, CA et al. Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy. Pediatr Blood Cancer, 2015;62:329–334.Google Scholar

Lester-Coll, NH, Morse, CB, Zhai, HA et al. Preserving fertility in adolescent girls and young women requiring craniospinal irradiation: a case report and discussion of options to be considered prior to treatment. J Adolesc Young Adult Oncol, 2014;3:96–99.Google Scholar

Perez-Andujar, A, Newhauser, WD, Taddei, PJ, Mahajan, A, Howell, RM. The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation. Phys Med Biol, 2013;58:3107–3123.Google Scholar

Jadoul, P, Anckaert, E, Dewandeleer, A et al. Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. Fertil Steril, 2011;96(1):126–133.Google Scholar

Sarafoglou, K, Boulad, F, Gillio, A, Sklar, C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr, 1997;130:210–216.Google Scholar

Jadoul, P, Donnez, J. How does bone marrow transplantation affect ovarian function and fertility? Curr Opin Obstet Gynecol, 2012;24:164–171.Google Scholar

Salooja, N, Szydlo, RM, Socie, G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet, 2001;358:271–276.Google Scholar

Lee, SJ, Schover, LR, Partridge, AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol, 2006;24:2917–2931.Google Scholar

Oktay, K, Harvey, BE, Partridge, AH et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol, 2018;36:1994–2001.Google Scholar

Druckenmiller, S, Goldman, KN, Labella, PA et al. Successful oocyte cryopreservation in reproductive-aged cancer survivors. Obstet Gynecol, 2016;127:474–480.Google Scholar

Rienzi, L, Gracia, C, Maggiulli, R et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update, 2017;23:139–155.Google Scholar

Argyle, CE, Harper, JC, Davies, MC. Oocyte cryopreservation: where are we now? Hum Reprod Update, 2016;22:440–449.Google Scholar

Donnez, J, Dolmans, MM, Diaz, C, Pellicer, A. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril, 2015;104:1097–1098.Google Scholar

Pacheco, F, Oktay, K. Current success and efficiency of autologous ovarian transplantation: a meta-analysis. Reprod Sci, 2017;24:1111–1120.Google Scholar

Van der Ven, H, Liebenthron, J, Beckmann, M et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod, 2016;31:2031–2041.Google Scholar

Flyckt, R. Ovarian cortical biopsy for fertility preservation. 2019 Oncofertility Conference, Chicago, Illinois. Presented November 13, 2019.Google Scholar

Xiao, S, Zhang, J, Romero, MM et al. In vitro follicle growth supports human oocyte meiotic maturation. Sci Rep, 2015;5:17323.Google Scholar

Luyckx, V, Dolmans, MM, Vanacker, J et al. A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold. Fertil Steril, 2014;101:1149–1156.Google Scholar

Prasath, EB, Chan, ML, Wong, WH et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod, 2014;29:276–278.Google Scholar

Segers, I, Mateizel, I, Van Moer, E et al. In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising “ex vivo” method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe. J Assist Reprod Genet, 2015;32:1221–1231.Google Scholar

Moawad, NS, Santamaria, E, Rhoton-Vlasak, A, Lightsey, JL. Laparoscopic ovarian transposition before pelvic cancer treatment: ovarian function and fertility preservation. J Minim Invasive Gynecol, 2017;24:28–35.Google Scholar

Fernandez-Pineda, I, Davidoff, AM, Lu, L et al. Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer, 2018;65: e27232.Google Scholar

Oktay, K, Oktem, O. Fertility preservation medicine: a new field in the care of young cancer survivors. Pediatr Blood Cancer, 2009;53:267–273.Google Scholar

Smith, KL, Gracia, C, Sokalska, A, Moore, H. Advances in fertility preservation for young women with cancer. Am Soc Clin Oncol Educ Book, 2018;38:27–37.Google Scholar

Blumenfeld, Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist, 2007;12:1044–1054.Google Scholar

Blumenfeld, Z, Zur, H, Dann, EJ. Gonadotropin-releasing hormone agonist cotreatment during chemotherapy may increase pregnancy rate in survivors. Oncologist, 2015;20:1283–1289.Google Scholar

Practice Committees of American Society for Reproductive Medicine SfART. Mature oocyte cryopreservation: a guideline. Fertil Steril, 2013;99:37–43.Google Scholar

Nightingale, CL, Quinn, GP, Shenkman, EA et al. Health-related quality of life of young adult survivors of childhood cancer: a review of qualitative studies. J Adolesc Young Adult Oncol, 2011;1:124–132.Google Scholar

Ginsberg, JP, Li, Y, Carlson, CA et al. Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making. Pediatr Blood Cancer, 2014;61:1673–1678.Google Scholar

Sullivan-Pyke, CS, Carlson, CA, Prewitt, M, Gracia, CR, Ginsberg, JP. Ovarian tissue cryopreservation (OTC) in prepubertal girls and young women: an analysis of parents’ and patients’ decision-making. J Assist Reprod Genet, 2018;35:593–600.Google Scholar

Nahata, L, Caltabellotta, NM, Yeager, ND et al. Fertility perspectives and priorities among male adolescents and young adults in cancer survivorship. Pediatr Blood Cancer, 2018;65: e27019.Google Scholar

Overbeek, A, van den Berg, M, Louwe, L et al. Practice, attitude and knowledge of Dutch paediatric oncologists regarding female fertility. Neth J Med, 2014;72:264–270.Google Scholar

Ataman, LM, Rodrigues, JK, Marinho, RM et al. Creating a global community of practice for oncofertility. J Glob Oncol, 2016;2:83–96.Google Scholar

Fitzmaurice, C, Akinyemiju, TF, Al Lami, FH et al. for the Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol, 2018 June 2. DOI:10.1001/jamaoncol.2018.2706. [Epub ahead of print]Google Scholar

Engholm, G, Ferlay, J, Christensen, N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries. Association of the Nordic Cancer Registries. Danish Cancer Society 2014.Google Scholar

Surveillance, Epidemiology, and End Results (SEER) 5-year relative survival by site. SEER cancer statistics review 1975–2008. www.seer.cancer.govGoogle Scholar

Oktay, K, Harvey, BE, Partridge, AH et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol, 2018 July 1;36(19):1994–2001.Google Scholar

Armuand, GM, Rodriguez-Wallberg, KA, Wettergren, L et al. Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol, 2012;30(17):2147–2153.Google Scholar

Armuand, GM, Wettergren, L, Rodriguez-Wallberg, KA, Lampic, C. Women more vulnerable than men when facing risk for treatment-induced infertility: a qualitative study of young adults newly diagnosed with cancer. Acta Oncol, 2015 February;54(2):243–552.Google Scholar

Fredholm, H, Eaker, S, Frisell, J et al. Breast cancer in young women: poor survival despite intensive treatment. PLoS One, 2009;4:e76957.Google Scholar

Curigliano, G, Burstein, HJ, Winer, EP et al.; Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol, 2018 May 3. DOI:10.1093/annonc/mdx806.[Epub ahead of print]Google Scholar

Rodriguez-Wallberg, KA. Principles of cancer treatment: impact on reproduction. Adv Exp Med Biol, 2012;732:1–8.Google Scholar

Sonmezer, M, Oktay, K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist, 2006;11(5):422–434.Google Scholar

Rodriguez-Wallberg, KA, Oktay, K. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer. Oncologist, 2012;17:1409–1417.Google Scholar

Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril, 2018 August;110(3):380–386.Google Scholar

Lambertini, M, Fontana, V, Massarotti, C et al. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: results of the pilot phase of the PREgnancy and FERtility (PREFER) study. Breast, 2018 June 22;41:51–56.Google Scholar

Rodriguez-Wallberg, KA, Tanbo, T, Tinkanen, H et al. Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries – compilation of 20 years of multicenter experience. Acta Obstet Gynecol Scand, 2016 September;95(9):1015–1026.Google Scholar

Oktay, K, Buyuk, E, Davis, O et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod, 2003;18(1):90–95.Google Scholar

Meirow, D, Raanani, H, Maman, E et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertil Steril, 2014 August;102(2):488–495.Google Scholar

Fisk, NM, Templeton, AA, Papadopoulos, GC, Matlin, SA, Wu, ZY. Lack of effect of high-dose antioestrogen on the maturation and in-vitro fertilization of human oocytes. Hum Reprod, 1989 July;4(5):584–587.Google Scholar

Tulandi, T, Martin, J, Al-Fadhli, R et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril, 2006;85(6):1761–1765.Google Scholar

Ata, B, Tulandi, T. Reassurance of safety of letrozole and suggested approaches in controlled ovarian hyperstimulation. Fertil Steril, 2009 July;92(1):e6.Google Scholar

Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab, 2006;91(10):3885–3890.Google Scholar

Azim, AA, Costantini-Ferrando, M, Lostritto, K, Oktay, K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab, 2007;92(6):2197–2200.Google Scholar

Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab, 2006 October;91(10):3885–3890.Google Scholar

Oktay, K, Türkçüoglu, I, Rodriguez-Wallberg, KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online, 2010;20(6):783–788.Google Scholar

Sönmezer, M1, Türkçüoğlu, I, Coşkun, U, Oktay, K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril, 2011 May;95(6):2125.e9–11.Google Scholar

Oktay, K, Buyuk, E, Rodriguez-Wallberg, KA, Sahin, G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online, 2010 May;20(5):634–638.Google Scholar

Gellert, SE, Pors, SE, Kristensen, SG et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet, 2018 April;35(4):561–570.Google Scholar

Azim, AA, Costantini-Ferrando, M, Oktay, K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol, 2008;26:2630–2635.Google Scholar

Kim, J, Turan, V, Oktay, K. Long-term safety of letrozone and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab, 2016;101(4):1364–1371, jc20153878.Google Scholar

Rodriguez-Wallberg, KA, Eloranta, S, Krawiec, K et al. Safety of fertility preservation in breast cancer patients in a register-based matched cohort study. Breast Cancer Res Treat 2018 February;167 (3):761–769.Google Scholar

Kroman, N, Jensen, MB, Wohlfahrt, J, Ejlertsen, B; Danish Breast Cancer Cooperative Group. Pregnancy after treatment of breast cancer–a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol, 2008;47(4):545–549.Google Scholar

Azim, HA Jr, Santoro, L, Pavlidis, N et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer, 2011 January;47(1):74–83.Google Scholar

Hartman, EK, Eslick, GD. The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis. Breast Cancer Res Treat, 2016 November;160(2):347–360.Google Scholar

Sankila, R, Heinävaara, S, Hakulinen, T. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol, 1994 March;170(3):818–823.Google Scholar

Dalberg, K, Eriksson, J, Holmberg, L. Birth outcome in women with previously treated breast cancer–a population-based cohort study from Sweden. PLoS Med, 2006;3(9):e336.Google Scholar

Marklund, A, Nasiell, J, Berger, AS, Fagerberg, A, Rodriguez-Wallberg, KA. Pregnancy achieved using donor eggs in cancer survivors with treatment-induced ovarian failure: obstetric and perinatal outcome. J Womens Health (Larchmt), 2018 July;27(7):939–945.Google Scholar

Oktem, O, Urman, B. Options of fertility preservation in female cancer patients. Obstet Gynecol Surv, 2010;65(8):531–542.Google Scholar

Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2018. CA Cancer J Clin, 2018;68(1):7–30.Google Scholar

Smith, A, Howell, D, Patmore, R, Jack, A, Roman, E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer, 2011;105(11):1684–1692.Google Scholar

Oktem, O, Kim, SS, Selek, U, Schatmann, G, Urman, B. Ovarian and uterine functions in female survivors of childhood cancers. Oncologist, 2018;23(2):214–224.Google Scholar

Plowchalk, DR, Mattison, DR. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Toxicol Appl Pharmacol, 1991;107(3):472–481.Google Scholar

Oktem, O, Oktay, K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer, 2007;110(10):2222–2229.Google Scholar

Meirow, D, Dor, J, Kaufman, B et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007;22(6):1626–1633.Google Scholar

Bildik, G, Akin, N, Senbabaoglu, F et al. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro. Hum Reprod, 2015;30(12):2912–2925.Google Scholar

Kalich-Philosoph, L, Roness, H, Carmely, A et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med, 2013;5(185):185ra162.Google Scholar

Morgan, S, Lopes, F, Gourley, C, Anderson, RA, Spears, N. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLoS One, 2013;8(7):e70117.Google Scholar

Himelstein-Braw, R, Peters, H, Faber, M. Morphological study of the ovaries of leukaemic children. Br J Cancer, 1978;38(1):82–87.Google Scholar

Epstein, RJ. Drug-induced DNA damage and tumor chemosensitivity. J Clin Oncol, 1990;8(12):2062–2084.Google Scholar

Antal, Z, Sklar, CA. Gonadal function and fertility among survivors of childhood cancer. Endocrinol Metab Clin North Am, 2015;44(4):739–749.Google Scholar

Oktem, O, Oktay, K. The ovary: anatomy and function throughout human life. Ann N Y Acad Sci, 2008;1127:1–9.Google Scholar

Oktem, O, Oktay, K. Preservation of menstrual function in adolescent and young females. Ann N Y Acad Sci, 2008;1135:237–243.Google Scholar

Bines, J, Oleske, DM, Cobleigh, MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol, 1996;14(5):1718–1729.Google Scholar

Wallace, WH, Thomson, AB, Kelsey, TW. The radiosensitivity of the human oocyte. Hum Reprod, 2003;18(1):117–121.Google Scholar

Ashwood-Smith, MJ, Edwards, RG. DNA repair by oocytes. Mol Hum Reprod, 1996;2(1):46–51.Google Scholar

Adriaens, I, Smitz, J, Jacquet, P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update, 2009;15(3):359–377.Google Scholar

Jaroudi, S, Kakourou, G, Cawood, S et al. Expression profiling of DNA repair genes in human oocytes and blastocysts using microarrays. Hum Reprod, 2009;24(10):2649–2655.Google Scholar

Himelstein-Braw, R, Peters, H, Faber, M. Influence of irradiation and chemotherapy on the ovaries of children with abdominal tumours. Br J Cancer, 1977;36(2):269–275.Google Scholar

Oktem, O, Oktay K. Preservation of menstrual function in adolescent and young females. Ann N Y Acad Sci, 2008; 1135:237–243.Google Scholar

Green DM, Kawashima T, Stovall M et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Cli Oncol, 2009;27(16):2677–2685.Google Scholar

Critchley, HO, Wallace, WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr, 2005;34:64–68.Google Scholar

Sudour, H, Chastagner, P, Claude, L et al. Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors. Int J Radiat Oncol Biol Phys, 2010;76(3):867–873.Google Scholar

Beneventi, F, Locatelli, E, Giorgiani, G et al. Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases. BJOG, 2014;121(7):856–865; discussion 865.Google Scholar

Hawkins, MM, Smith, RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer, 1989;43(3):399–402.Google Scholar

Knopman, JM, Papadopoulos, EB, Grifo, JA et al. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol, 2010;11(5):490–498.Google Scholar

Critchley, HO, Bath, LE, Wallace, WH, Radiation damage to the uterus – review of the effects of treatment of childhood cancer. Hum Fertil (Camb), 2002;5(2):61–66.Google Scholar

Norwitz, ER, Stern, HM, Grier, H, Lee-Parritz, A. Placenta percreta and uterine rupture associated with prior whole body radiation therapy. Obstet Gynecol, 2001;98(5 Pt 2):929–931.Google Scholar

Teh, WT et al. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int, 2014;2014:482968.Google Scholar

Barton, SE et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol, 2013; 14(9):873–881.Google Scholar

Gill, S, Blackstock, AW, Goldberg, RM, Colorectal cancer. Mayo Clin Proc, 2007; 82(1):114–129.Google Scholar

Maindrault-Goebel, F, et al. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Eur J Cancer, 1999; 35(9):1338–1342.Google Scholar

Fuchs, CS et al. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICCC Study. J Clin Oncol, 2007; 25(30):4779–4786.Google Scholar

Douillard, JY et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med, 2013; 369(11):1023–1034.Google Scholar

Cercek, A et al. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clin Colorectal Cancer, 2013;12(3):163–167.Google Scholar

Wan, J et al. Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin Colorectal Cancer, 2015;14(1):31–34.Google Scholar

Utsunomiya, T et al. A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis. Int J Oncol, 2008;32(5):991–1000.Google Scholar

Tanaka, T et al. Irinotecan HCl, an anticancer topoisomerase I inhibitor, frequently induces ovarian failure in premenopausal and perimenopausal women. Oncol Rep, 2008;19(5):1123–1133.Google Scholar

FDA, A.d.Google Scholar

Zamah, AM et al. Will imatinib compromise reproductive capacity? Oncologist, 2011;16(10):1422–1427.Google Scholar

Christopoulos, C, Dimakopoulou, V, Rotas, E. Primary ovarian insufficiency associated with imatinib therapy. N Engl J Med, 2008;358(10):1079–1080.Google Scholar

Gonfloni, S et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy induced death. Nat Med, 2009;15(10):1179–1185.Google Scholar

Kerr, JB et al. Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib. Nat Med, 2012;18(8):1170–1172; author reply 1172–1174.Google Scholar

Bildik, G C-Abl is not activated in DNA damage-induced and Tap63-mediated oocyte apoptosis in human ovary. Cell Death Dis, 2018;9(10):943.Google Scholar

Jou, E, Rajdev, L. Current and emerging therapies in unresectable and recurrent gastric cancer. World J Gastroenterol, 2016;22(20):4812–4823.Google Scholar

Berliere, M et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer, 2008;8:56.Google Scholar

Nabholtz, JPT, Mackey, J. Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 001 study. Proc Annu Meet Am Soc Clin Oncol, 2002;141 (Abstract).Google Scholar

Hortobagyi, GN et al. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr, 1986(1):105–109.Google Scholar

Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med, 1985;312(23):1465–1472.Google Scholar

Krook, JE et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med, 1991;324(11):709–715.Google Scholar

Tveit, KM et al. Randomized controlled trial of postoperative radiotherapy and short-term time scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg, 1997;84(8):1130–1135.Google Scholar

O’Connell, MJ et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med, 1994;331(8):502–507.Google Scholar

Tepper, JE et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol, 1997;15(5):2030–2039.Google Scholar

Tepper, JE et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control–final report of intergroup 0114. J Clin Oncol, 2002;20(7):1744–1750.Google Scholar

Fietkau, R, Rodel, C. [Postoperative radiochemotherapy of rectal carcinoma reduces the incidence of locoregional recurrences but does not improve the prognosis of patients–the results of a randomized study of the NSABP-R02. National Surgical Adjuvant Breast and Bowel Project Protocol]. Strahlenther Onkol, 2000;176(8):381–382.Google Scholar

Wolmark, N et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst, 2000;92(5):388–396.Google Scholar